Literature DB >> 29382247

Antibiotic-loaded cement spacers - lessons learned from the past 20 years.

Konstantinos Anagnostakos1, Bernd Fink2.   

Abstract

INTRODUCTION: The use of antibiotic-impregnated cement spacers is an established method in the treatment of periprosthetic hip and knee joint infections. Over the past 20 years, the indications for spacer implantation have expanded, and various modified surgical techniques have been proposed to manage difficult anatomical situations. To ensure clinical success, knowledge about the cement impregnation and the pharmacokinetic properties of antibiotic-loaded bone cement is an indispensable premise. AREAS COVERED: In this review, techniques for the fabrication of cement spacers, the incorporation of antibiotics into bone cement, elution kinetics, the clinical performance of spacers, individualized surgical techniques as well as possible postoperative complications are presented. Moreover, the possibility of bacterial colonization of cement spacers during the interim phase which might lead to persistence of infection is also discussed. EXPERT COMMENTARY: The use of articulating spacers is established in hip surgery. However, in knee surgery it is still debated whether articulating or static spacers provide more advantages. The concern about the possible colonization of antibiotic-loaded spacers during the interim phase does not seem to be actually substantiated by hard scientific data due to the lack of important information in the published studies.

Entities:  

Keywords:  Joint infection; antibiotic-loaded cement; hip spacer; knee spacer; spacer dislocation; spacer fracture

Mesh:

Substances:

Year:  2018        PMID: 29382247     DOI: 10.1080/17434440.2018.1435270

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  7 in total

1.  Successful Two-Stage Exchange Arthroplasty for Periprosthetic Infection Following Total Knee Arthroplasty: The Impact of Timing on Eradication of Infection.

Authors:  Ines Vielgut; Gerold Schwantzer; Andreas Leithner; Patrick Sadoghi; Uldis Berzins; Mathias Glehr
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

2.  A spacer infection by Candida albicans secondary to a Staphylococcus capitis prosthetic joint infection: a case report.

Authors:  Marta Bottagisio; Alessandro Bidossi; Nicola Logoluso; Antonio Pellegrini; Elena De Vecchi
Journal:  BMC Infect Dis       Date:  2021-05-04       Impact factor: 3.090

3.  Are Cement Spacers and Beads Loaded with the Correct Antibiotic(s) at the Site of Periprosthetic Hip and Knee Joint Infections?

Authors:  Konstantinos Anagnostakos; Ismail Sahan
Journal:  Antibiotics (Basel)       Date:  2021-02-01

Review 4.  Current Concepts on the Application, Pharmacokinetics and Complications of Antibiotic-Loaded Cement Spacers in the Treatment of Prosthetic Joint Infections.

Authors:  Panagiotis V Samelis; Eftychios Papagrigorakis; Eleni Sameli; Andreas Mavrogenis; Olga Savvidou; Panagiotis Koulouvaris
Journal:  Cureus       Date:  2022-01-05

Review 5.  Antifungal-Loaded Acrylic Bone Cement in the Treatment of Periprosthetic Hip and Knee Joint Infections: A Review.

Authors:  Konstantinos Anagnostakos; Sören L Becker; Ismail Sahan
Journal:  Antibiotics (Basel)       Date:  2022-06-30

Review 6.  Are Static Spacers Superior to Articulated Spacers in the Staged Treatment of Infected Primary Knee Arthroplasty? A Systematic Review and Meta-Analysis.

Authors:  Michele Fiore; Andrea Sambri; Matteo Filippini; Lorenzo Morante; Claudio Giannini; Azzurra Paolucci; Claudia Rondinella; Renato Zunarelli; Pierluigi Viale; Massimiliano De Paolis
Journal:  J Clin Med       Date:  2022-08-18       Impact factor: 4.964

7.  Positive Microbiological Findings at the Site of Presumed Aseptic Revision Arthroplasty Surgery of the Hip and Knee Joint: Is a Surgical Revision Always Necessary?

Authors:  Konstantinos Anagnostakos; Andreas Thiery; Christof Meyer; Ismail Sahan
Journal:  Biomed Res Int       Date:  2020-05-09       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.